NO893367D0 - Alfa-underenheten av mac-1 leukocytadhesjons-reseptoren. - Google Patents

Alfa-underenheten av mac-1 leukocytadhesjons-reseptoren.

Info

Publication number
NO893367D0
NO893367D0 NO893367A NO893367A NO893367D0 NO 893367 D0 NO893367 D0 NO 893367D0 NO 893367 A NO893367 A NO 893367A NO 893367 A NO893367 A NO 893367A NO 893367 D0 NO893367 D0 NO 893367D0
Authority
NO
Norway
Prior art keywords
mac
leukocyte adhesion
adhesion receptor
alfa
subunit
Prior art date
Application number
NO893367A
Other languages
English (en)
Other versions
NO893367L (no
Inventor
Timothy Springer
Angel Corbi
Original Assignee
Dana Farber Cancer Inst Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dana Farber Cancer Inst Inc filed Critical Dana Farber Cancer Inst Inc
Publication of NO893367D0 publication Critical patent/NO893367D0/no
Publication of NO893367L publication Critical patent/NO893367L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2839—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
    • C07K16/2845—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily against integrin beta2-subunit-containing molecules, e.g. CD11, CD18
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70525—ICAM molecules, e.g. CD50, CD54, CD102
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70546—Integrin superfamily
    • C07K14/70553—Integrin beta2-subunit-containing molecules, e.g. CD11, CD18
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO89893367A 1988-08-23 1989-08-22 Alfa-underenheten av mac-1 leukocytadhesjons-reseptoren. NO893367L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23535388A 1988-08-23 1988-08-23
US32123989A 1989-03-09 1989-03-09

Publications (2)

Publication Number Publication Date
NO893367D0 true NO893367D0 (no) 1989-08-22
NO893367L NO893367L (no) 1990-02-26

Family

ID=26928829

Family Applications (1)

Application Number Title Priority Date Filing Date
NO89893367A NO893367L (no) 1988-08-23 1989-08-22 Alfa-underenheten av mac-1 leukocytadhesjons-reseptoren.

Country Status (13)

Country Link
US (3) US5849896A (no)
EP (1) EP0364690A3 (no)
JP (1) JPH0347077A (no)
KR (1) KR0185964B1 (no)
AU (1) AU638937B2 (no)
CA (1) CA1341293C (no)
DK (1) DK412489A (no)
FI (1) FI893917L (no)
HU (1) HU213014B (no)
IL (1) IL91370A (no)
NO (1) NO893367L (no)
NZ (1) NZ230397A (no)
PT (1) PT91502B (no)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988006592A1 (en) * 1987-02-26 1988-09-07 Dana-Farber Cancer Institute, Inc. Cloning of lfa-1
US5395929A (en) * 1987-12-15 1995-03-07 Dana Farber Cancer Institute Isolated nucleic acid encoding the alpha subunit of the human leukocyte adhesion receptor
US5877275A (en) * 1988-06-28 1999-03-02 The General Hospital Corporation Controlling cellular immune/inflammatory responses with β2 integrins
EP0364690A3 (en) 1988-08-23 1990-07-18 Dana Farber Cancer Institute The alpha-subunit of the mac-1 leukocyte adhesion receptor
US6051231A (en) * 1988-09-01 2000-04-18 Bayer Corporation Antiviral methods and prepations
US6514936B1 (en) 1988-09-01 2003-02-04 Bayer Corporation Antiviral methods using human rhinovirus receptor (ICAM-1)
US6143298A (en) * 1988-09-01 2000-11-07 Bayer Corporation Soluble truncated forms of ICAM-1
ZA896668B (en) * 1988-09-01 1990-06-27 Molecular Therapeutics Inc A human rhinovirus receptor protein that inhibits virus infectivity
JPH04505009A (ja) * 1989-03-09 1992-09-03 ダナ・ファーバー・キャンサー・インスティチュート クローニングｌｆａ―１
JPH04505613A (ja) * 1989-03-09 1992-10-01 ダナ・ファーバー・キャンサー・インスティチュート 白血球付着レセプター
US6107461A (en) * 1990-07-20 2000-08-22 Bayer Corporation Multimeric forms of human rhinovirus receptor and fragments thereof, and method of use
US5686581A (en) * 1990-07-20 1997-11-11 Bayer Corporation Multimeric form of human rhinovirus receptor protein
US5686582A (en) * 1990-07-20 1997-11-11 Bayer Corporation Multimeric forms of human rhinovirus receptor protein
ES2134762T3 (es) * 1990-07-20 1999-10-16 Bayer Ag Formas multimericas de proteinas receptoras de rinovirus humanos.
AU674556B2 (en) * 1992-10-09 1997-01-02 Center For Blood Research, Inc., The A subpopulation of MAC-1 molecules which mediate neutrophil adhesion to ICAM-1 and fibrinogen
WO1995029243A1 (en) * 1994-04-26 1995-11-02 Pharmacia & Upjohn Company Mac-1 i-domain protein useful in blocking adhesion and migration of neutrophils
WO1996001644A1 (en) * 1994-07-11 1996-01-25 Athena Neurosciences, Inc. Inhibitors of leukocyte adhesion
US5696229A (en) * 1995-03-16 1997-12-09 The University Of Virginia Patent Foundation Polypeptide with laminin cell adhesion and morphogenesis activity
US6037454A (en) 1996-11-27 2000-03-14 Genentech, Inc. Humanized anti-CD11a antibodies
US7400477B2 (en) 1998-08-24 2008-07-15 Leviton Manufacturing Co., Inc. Method of distribution of a circuit interrupting device with reset lockout and reverse wiring protection
US6210897B1 (en) 1999-05-26 2001-04-03 Leif Andersson Identification of canine leukocyte adhesion deficiency in dogs
WO2001070266A2 (en) 2000-03-17 2001-09-27 Millennium Pharmaceuticals, Inc. Method of inhibiting stenosis and restenosis with a mixture of antibodies anti cd18 and anti ccr2
AU2001287000A1 (en) * 2000-09-01 2002-03-13 The Center For Blood Research, Inc. Modified polypeptides stabilized in a desired conformation and methods for producing same
US7372678B2 (en) * 2005-08-24 2008-05-13 Leviton Manufacturing Co., Inc. Circuit interrupting device with automatic test
US7852606B2 (en) * 2005-08-24 2010-12-14 Leviton Manufacturing Company, Inc. Self-testing circuit interrupting device
US7911746B2 (en) * 2006-06-01 2011-03-22 Leviton Manufacturing Co., Inc. GFCI with self-test and remote annunciation capabilities
US8603628B2 (en) * 2007-04-30 2013-12-10 Saint-Gobain Performance Plastics Corporation Turbine blade protective barrier
CN101910856B (zh) 2008-01-29 2014-06-18 立维腾制造有限公司 自测试故障电路中断器装置和方法
US9759758B2 (en) 2014-04-25 2017-09-12 Leviton Manufacturing Co., Inc. Ground fault detector

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4761371A (en) * 1985-02-12 1988-08-02 Genentech, Inc. Insulin receptor
US5424399A (en) * 1988-06-28 1995-06-13 The Children's Medical Center Corporation Human CR3α/β heterodimers
EP0364690A3 (en) 1988-08-23 1990-07-18 Dana Farber Cancer Institute The alpha-subunit of the mac-1 leukocyte adhesion receptor

Also Published As

Publication number Publication date
FI893917A0 (fi) 1989-08-21
EP0364690A2 (en) 1990-04-25
EP0364690A3 (en) 1990-07-18
PT91502A (pt) 1990-03-08
AU4014489A (en) 1990-03-01
IL91370A (en) 1995-07-31
US20020022595A1 (en) 2002-02-21
DK412489A (da) 1990-02-24
HUT54207A (en) 1991-01-28
US6683158B2 (en) 2004-01-27
KR0185964B1 (ko) 1999-05-01
HU213014B (en) 1997-01-28
FI893917A7 (fi) 1990-02-24
CA1341293C (en) 2001-09-18
KR900002797A (ko) 1990-03-23
NZ230397A (en) 1997-07-27
NO893367L (no) 1990-02-26
DK412489D0 (da) 1989-08-22
FI893917L (fi) 1990-02-24
US5849896A (en) 1998-12-15
PT91502B (pt) 1995-05-04
US20030013850A1 (en) 2003-01-16
JPH0347077A (ja) 1991-02-28
AU638937B2 (en) 1993-07-15
IL91370A0 (en) 1990-04-29

Similar Documents

Publication Publication Date Title
NO893367D0 (no) Alfa-underenheten av mac-1 leukocytadhesjons-reseptoren.
FI872878L (fi) Foerfarande foer framstaellning av nya algininsyraestrar.
DE68914344D1 (de) Immununterdrückende Verbindungen.
FI874702L (fi) Foerfarande foer framstaellning av nya benzimidazolderivater.
DE3870218D1 (de) Ringfoermige flanschverbindung.
ES2016843B3 (es) Aumento de duracion de la polimerizacion usando oxianiones sililados.
FI872808A0 (fi) Nya topiskt applicerbara farmaceutiska sammansaettningar med systemisk verkan.
FI871175L (fi) Nya plasminogenaktivatorpolypeptider av human vaevnadstyp.
DE3766468D1 (de) Kettengestricktes haftverschlusstragband.
FI871406A0 (fi) Foerfarande foer framstaellning av nya aminosyraderivat.
DE58908391D1 (de) ECL-CMOS-Wandler.
FI875438A0 (fi) Foerfarande foer framstaellning av nya pyrrolobenzimidazoler.
DE59004478D1 (de) Haftvermittler.
DE58907227D1 (de) Haftvermittler.
FI884804L (fi) Foerfarande foer framstaellning av amino-1,3-benzendiol.
FI873518A0 (fi) Foerfarande foer polymerisation av a-olefin.
FI885544A7 (fi) Nya foereningar.
FI883146L (fi) Nya foereningar.
NO891824L (no) Klebemiddelblandinger.
DE3885378D1 (de) Nippelfutter.
NO875391D0 (no) Segment-deskriptorenhet.
FI872489A0 (fi) Foerfarande foer framstaellning av nya aralkylimidazolderivat.
FI875095A7 (fi) Foerfarande foer framstaellning av nya substituerade aminometandifosfonsyror.
FI875766A7 (fi) Foerfarande foer framstaellning av nya pyrimidinderivat.
DE3870279D1 (de) Behaelterauskleidung.